Cancer research data is particularly attractive to cybercriminals for several reasons. Firstly, it contains highly sensitive personal and medical information that can be used for identity theft or sold on the black market. Secondly, proprietary research findings can be extremely valuable to competitors in the pharmaceutical and biotech industries. Lastly, the medical and research sector often lags in cybersecurity measures compared to other industries, making it an easier target.
